ALLMedicine™ Hyperparathyroidism Center
Research & Reviews 3,882 results
https://doi.org/10.1016/j.acra.2023.02.020
Academic Radiology; Chai HH, Dai ZJ et. al.
Mar 26th, 2023 - To compare the clinical and economic effects of ultrasound (US)-guided radiofrequency ablation (RFA) with parathyroidectomy (PTX) for primary hyperparathyroidism (PHPT). From April 2014 to April 2021, 123 PHPT patients who received US-guided RFA o...
https://doi.org/10.1210/endrev/bnad009
Endocrine Reviews; Jha S, Simonds WF
Mar 25th, 2023 - Recent data suggest an increase in the overall incidence of parathyroid disorders with primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is associated with morbidities (fractures, kidney stones, chronic kidney ...
https://doi.org/10.1530/JOE-22-0319
The Journal of Endocrinology; David K, Dubois V et. al.
Mar 24th, 2023 - Patients suffering from chronic kidney disease (CKD) often experience bone loss and arterial calcifications. It is unclear if hypogonadism contributes to the development of these complications, and whether androgen therapy might prevent them. Male...
https://doi.org/10.2214/AJR.23.29049
AJR. American Journal of Roentgenology; Bunch PM, Aribindi S et. al.
Mar 23rd, 2023 - Background: Existing gaps in primary hyperparathyroidism (PHPT) diagnosis and treatment have prompted calls for systemic change in the approach to this disease. One proposed change is opportunistic assessment for enlarged parathyroid glands on rou...
http://emedicine.medscape.com/article/334377-medication
Mar 21st, 2023 - Medication Summary Several drugs, either alone or in combination with sympathetic blockade, may be efficacious in prolonging the duration of symptomatic relief. Some of these drugs reduce the activity of the sympathetic nervous system, whereas oth...
Guidelines 6 results
https://doi.org/10.1016/j.jacr.2021.08.013
Journal of the American College of Radiology : JACR; , Zander D et. al.
Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118036
Journal of Nephrology; Bellasi A, Cozzolino M et. al.
Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...
https://doi.org/10.1093/ageing/afu093
Age and Ageing; Aspray TJ, Bowring C et. al.
Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...
https://www.ncbi.nlm.nih.gov/pubmed/22824948
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.
Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,
https://doi.org/10.1136/ard.2010.139105
Annals of the Rheumatic Diseases; Zhang W, Doherty M et. al.
Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...
Drugs 180 results see all →
Clinicaltrials.gov 366 results
https://clinicaltrials.gov/ct2/show/NCT01660984
Mar 17th, 2023 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...
https://clinicaltrials.gov/ct2/show/NCT05761743
Mar 9th, 2023 - Primary hyperparathyroidism (PHPT) is known to affect the kidney and skeletal system, however, recent data have suggested that patients can also exhibit an increased cardiovascular risk and metabolic abnormalities Primary hyperparathyroidism (PHPT...
https://clinicaltrials.gov/ct2/show/NCT04064827
Feb 27th, 2023 - The main objective of this study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9 years with SHPT associated with stage 5 CKD receiving Peritoneal Dialysis (PD) or Hemo...
https://clinicaltrials.gov/ct2/show/NCT03931109
Feb 24th, 2023 - Osteoporosis and osteopenia are chronic diseases disproportionately affecting the elderly. In the United States, the prevalence of osteoporosis is projected to increase from 10 million in 2005 to 14 million in 2025, due to population aging. Simila...
https://clinicaltrials.gov/ct2/show/NCT05543928
Feb 24th, 2023 - This is a phase 3, multi-center, randomized, double-blind, placebo-controlled study in children with stage 3-4 chronic kidney disease (CKD), secondary hyperparathyroidism (SHPT) and vitamin D insufficiency.
News 235 results
https://www.medpagetoday.com/endocrinology/generalendocrinology/102656
Jan 17th, 2023 - Oral semaglutide (Rybelsus) received an expanded label to include first-line treatment for adults with type 2 diabetes as an adjunct to diet and exercise, Novo Nordisk announced. The Obesity Society and Obesity Action Coalition lent support to the...
https://www.medpagetoday.com/endocrinology/generalendocrinology/102395
Dec 27th, 2022 - The Endocrine Society released new guidelines for treating hypercalcemia of malignancy in adults. (The Journal of Clinical Endocrinology & Metabolism) Childhood cancer survivors -- especially females -- may carry an increased risk for fractures. (...
https://www.mdedge.com/psychiatry/article/259828/bipolar-disorder/lithium-associated-hypercalcemia-monitoring-and
Sumeet Gupta, MD, Adityo Khastgir, MBBS
Dec 1st, 2022 - Hypercalcemia is a well-known but underrecognized adverse effect of lithium. Most patients with lithium-associated hypercalcemia (LAH) have either nonspecific symptoms (eg, persistent tiredness, constipation, polyuria, polydipsia) or no symptoms.
https://www.mdedge.com/dermatology/article/258269/dermatopathology/tender-nonhealing-lesion-leg
Austinn C. Miller, MD, Mojahed Mohammad K. Shalabi, MD et. al.
Sep 28th, 2022 - The Diagnosis: Calciphylaxis Calciphylaxis is a rare life-threatening condition that most often is seen in patients with end-stage renal disease at a rate of 35 per 10,000 chronic dialysis patients. 1 It less commonly has been described in nonuremi.
https://www.medscape.com/viewarticle/977964
Aug 19th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...